Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

May 8, 2013

5229_dirs_2013-05-08_3dcec7e1-963e-4a1c-b300-8433d619f970.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2404E

AstraZeneca PLC

08 May 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below. 

On 7 May 2013, Mr Lowth received shares from the vesting of a previously announced award made in May 2010 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, he has now become beneficially entitled to 47% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name Shares awarded Shares vested Shares withheld Net shares received Market price on vesting
Simon Lowth 52,009 24,444 11,489 12,955 3339.5p

As a result of this transaction, Mr Lowth has an interest in 260,877 ordinary shares, which represents approximately 0.02% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

8 May 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUWORROSAVRAR